ABIVAX Socit Company Top Executives

AAVXF Stock  USD 12.36  0.00  0.00%   
ABIVAX Socit employes about 24 people. The company is managed by 26 executives with a total tenure of roughly 11 years, averaging almost 0.0 years of service per executive having 0.92 employees per reported executive. Examination of ABIVAX Socit management performance can provide insight into the company performance. Note, employee analysis is becoming a valuable factor that investors use to determine the amount of risk that may be associated with ABIVAX Socit Anonyme future performance.
Hartmut Ehrlich  CEO
Philippe Pouletty  Chairman
Chairman of the Board
Bernard Fanget  President
Vice President - Process Development and Manufacturing
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in national income and product accounts.

ABIVAX Socit Management Team Effectiveness

The company has return on total asset (ROA) of (0.4368) % which means that it has lost $0.4368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.8647) %, meaning that it generated substantial loss on money invested by shareholders. ABIVAX Socit's management efficiency ratios could be used to measure how well ABIVAX Socit manages its routine affairs as well as how well it operates its assets and liabilities.

ABIVAX Socit Workforce Comparison

ABIVAX Socit Anonyme is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 302,955. ABIVAX Socit adds roughly 24.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

ABIVAX Socit Anonyme Benchmark Summation

The output start index for this execution was zero with a total number of output elements of sixty-one. ABIVAX Socit Anonyme Price Series Summation is a cross summation of ABIVAX Socit price series and its benchmark/peer.

ABIVAX Socit Notable Stakeholders

An ABIVAX Socit stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABIVAX Socit often face trade-offs trying to please all of them. ABIVAX Socit's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABIVAX Socit's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hartmut EhrlichCEOProfile
Philippe PoulettyChairman of the BoardProfile
Bernard FangetVice President - Process Development and ManufacturingProfile
Didier ScherrerVice President - Research & Development Small MoleculesProfile
Vincent SerraVice President - Research & Development Viral VaccinesProfile
Alexandra PearceVice President and Head of Regulatory AffairsProfile
Karl BirthistleVice President Chief Medical Officer and Vice President Clinical & Regulatory AffairsProfile
Pierre CourteilleVice President - Business Development, Chief Commercial OfficerProfile
Didier BlondelCFO, Board SecretaryProfile
Miguel SielerDirectorProfile
Christian PierretDirectorProfile
JeanJacques BertrandDirectorProfile
Jerome GallotDirectorProfile
Claude BertrandDirectorProfile
Joy AmundsonDirectorProfile
Antoine PauDirectorProfile
JeanPaul PrieelsDirectorProfile
Alain ChevallierAdvisorProfile
Philippe MDFounder DirectorProfile
Prof EhrlichChief OfficerProfile
Paul GinesteVP OperationsProfile
Pierre MBAChief DevelProfile
Regina JehleVP CommunicationsProfile
JeanMarc SteensChief Medical OfficerProfile
Anne PascardHR MangProfile
Raquel LizarragaInvestor MangProfile

About ABIVAX Socit Management Performance

The success or failure of an entity such as ABIVAX Socit Anonyme often depends on how effective the management is. ABIVAX Socit management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABIVAX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABIVAX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.
The data published in ABIVAX Socit's official financial statements usually reflect ABIVAX Socit's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ABIVAX Socit Anonyme. For example, before you start analyzing numbers published by ABIVAX accountants, it's critical to develop an understanding of what ABIVAX Socit's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ABIVAX Socit's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABIVAX Socit's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ABIVAX Socit's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ABIVAX Socit Anonyme. Please utilize our Beneish M Score to check the likelihood of ABIVAX Socit's management manipulating its earnings.

ABIVAX Socit Workforce Analysis

Traditionally, organizations such as ABIVAX Socit use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABIVAX Socit within its industry.

ABIVAX Socit Manpower Efficiency

Return on ABIVAX Socit Manpower

Revenue Per Employee1.5K
Revenue Per Executive1.4K
Net Loss Per Employee1.7M
Net Loss Per Executive1.6M
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in national income and product accounts.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for ABIVAX Pink Sheet analysis

When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Please note, there is a significant difference between ABIVAX Socit's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABIVAX Socit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABIVAX Socit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.